Analysen von Ravi Mehrotra

11.12.12 Biogen outperform Credit Suisse Group
13.11.12 Gilead Sciences neutral Credit Suisse Group
06.11.12 Amgen outperform Credit Suisse Group
18.10.12 Actelion outperform Credit Suisse Group
01.08.12 Vertex Pharmaceuticals outperform Credit Suisse Group
26.07.12 Amgen outperform Credit Suisse Group
04.04.12 Actelion outperform Credit Suisse Group
12.12.11 Gilead Sciences neutral Credit Suisse Group
29.11.11 Gilead Sciences neutral Credit Suisse Group
29.08.11 Human Genome Sciences outperform Credit Suisse Group
24.06.11 Biogen outperform Credit Suisse Group
26.04.11 Amgen neutral Credit Suisse Group
21.04.11 Gilead Sciences outperform Credit Suisse Group
18.04.11 Human Genome Sciences outperform Credit Suisse Group
11.04.11 Amgen neutral Credit Suisse Group
08.04.11 Biogen neutral Credit Suisse Group
11.03.11 Human Genome Sciences outperform Credit Suisse Group
03.02.11 Biogen neutral Credit Suisse Group
28.01.11 Celgene neutral Credit Suisse Group
26.01.11 Gilead Sciences outperform Credit Suisse Group
25.01.11 Amgen neutral Credit Suisse Group
21.01.11 Gilead Sciences outperform Credit Suisse Group
17.12.10 Celgene neutral Credit Suisse Group
15.12.10 Amgen neutral Credit Suisse Group
07.12.10 Gilead Sciences outperform Credit Suisse Group
07.12.10 Biogen neutral Credit Suisse Group
07.12.10 Celgene neutral Credit Suisse Group
08.12.10 Amgen neutral Credit Suisse Group